Cargando…
Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency
Functional elimination of p53 is a common feature of a large percentage of human malignancies. Here, we report the development of a pharmacological strategy aimed at restoring p53 function and its use for targeted therapy in p53-deficient mice. Specific inhibition of deubiquitinases ubiquitin-specif...
Autores principales: | Ma, Yu-Shui, Wang, Xiao-Feng, Zhang, Yun-Jie, Luo, Pei, Long, Hui-Deng, Li, Liu, Yang, Hui-Qiong, Xie, Ru-Ting, Jia, Cheng-You, Lu, Gai-Xia, Chang, Zheng-Yan, Zhang, Jia-Jia, Xue, Shao-Bo, Lv, Zhong-Wei, Yu, Fei, Xia, Qing, Fu, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005481/ https://www.ncbi.nlm.nih.gov/pubmed/32055678 http://dx.doi.org/10.1016/j.omto.2019.12.013 |
Ejemplares similares
-
Inhibition of USP14 and UCH37 deubiquitinating activity by b-AP15 as a potential therapy for tumors with p53 deficiency
por: Ma, Yu-Shui, et al.
Publicado: (2020) -
USP14 promotes pyroptosis of human annulus fibrosus cells derived from patients with intervertebral disc degeneration through deubiquitination of NLRP3: USP14 induces deubiquitination of NLRP3
por: Hai, Bao, et al.
Publicado: (2022) -
Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with p53 Deficiency
por: Jiang, Zong-Yuan, et al.
Publicado: (2022) -
Deubiquitination of Dishevelled by Usp14 is required for Wnt signaling
por: Jung, H, et al.
Publicado: (2013) -
Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11
por: Vlasschaert, Caitlyn, et al.
Publicado: (2015)